{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T06:42:42Z","timestamp":1790923362780,"version":"4.1.0"},"reference-count":44,"publisher":"European Respiratory Society (ERS)","issue":"1","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["ERJ Open Res"],"accepted":{"date-parts":[[2025,8,27]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Transient tachypnoea of the newborn (TTN) is a common cause of early respiratory distress, especially after caesarean delivery. Salbutamol, a \u03b2\n                      <jats:sub>2<\/jats:sub>\n                      -agonist, may enhance alveolar fluid clearance and improve outcomes. The objective of the present study was to evaluate the benefits and harms of nebulised salbutamol compared with placebo or standard care in neonates with TTN, through a systematic review and meta-analysis of randomised controlled trials (RCTs).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a systematic search of five electronic databases and trial registries up to April 2025. Risk of bias was assessed with the Cochrane Risk of Bias 1 tool, and certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. Meta-analyses were performed when appropriate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>21 RCTs (n=1223) were included. Repeated doses of salbutamol probably reduce hospital stay by 2.3\u2005days (mean difference (MD) \u22122.3 days, 95% CI \u22123.2 to \u22121.4 days; moderate certainty) and a single dose may reduce oxygen therapy duration by 19.4\u2005h (MD \u221219.4 h, 95% CI \u221226.0 to \u221212.9 h; low certainty) and duration of assisted ventilation by 12.7\u2005h (MD \u221212.7 h, 95% CI \u221219.6 to \u22125.7 h; low certainty). Effects on need for mechanical ventilation (risk ratio 0.37, 95% CI 0.07\u20131.96; very low certainty) and continuous positive airway pressure (risk ratio 0.84, 95% CI 0.59\u20131.19; very low certainty) were very uncertain. In addition, single dose of salbutamol may reduce tachypnoea duration by 6.6\u2005h (MD \u22126.6 h, 95% CI \u221212.6 to \u22120.7 h; low certainty) and clinical severity scores at 4 and 8\u2005h (MD \u22123.0 and \u22123.4 points, respectively; low certainty).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Salbutamol shows modest benefits in TTN, particularly in reducing oxygen therapy duration and hospital stay with repeated doses. However, given the low certainty of the evidence for most outcomes, its use should be carefully weighed within each healthcare context. Further high-quality trials are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1183\/23120541.00741-2025","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T16:55:27Z","timestamp":1757609727000},"page":"00741-2025","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Effects of salbutamol in transient tachypnoea of the newborn: a systematic review and meta-analysis"],"prefix":"10.1183","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7888-0122","authenticated-orcid":false,"given":"Roxana","family":"Aznaran-Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Nombera-Lossio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Nombera-Aznaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8435-847X","authenticated-orcid":false,"given":"Milagros","family":"Nombera-Aznaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fernandez-Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"2026022301501357000_12.1.00741-2025.1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0112-2024"},{"key":"2026022301501357000_12.1.00741-2025.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41372-020-0757-3"},{"key":"2026022301501357000_12.1.00741-2025.3","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-013-9475-3"},{"key":"2026022301501357000_12.1.00741-2025.4","doi-asserted-by":"publisher","DOI":"10.1053\/j.semperi.2006.01.006"},{"key":"2026022301501357000_12.1.00741-2025.5","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00092.2002"},{"key":"2026022301501357000_12.1.00741-2025.6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1015"},{"key":"2026022301501357000_12.1.00741-2025.7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00404-010-1473-6","article-title":"Transient tachypnoea of the newborn: effects of labour and delivery type in term and preterm pregnancies","volume":"283","author":"Derbent","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"2026022301501357000_12.1.00741-2025.8","doi-asserted-by":"publisher","DOI":"10.1542\/neo.18-3-e141"},{"key":"2026022301501357000_12.1.00741-2025.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2431-11-89"},{"key":"2026022301501357000_12.1.00741-2025.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2012.02.002"},{"key":"2026022301501357000_12.1.00741-2025.11","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.2174\/1381612811209023046","article-title":"Transient tachypnoea of the newborn: the treatment strategies","volume":"18","author":"Yurdakok","year":"2012","journal-title":"Curr Pharm Des"},{"key":"2026022301501357000_12.1.00741-2025.12","first-page":"CD011878","article-title":"Salbutamol for transient tachypnoea of the newborn","volume":"2","author":"Moresco","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026022301501357000_12.1.00741-2025.13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/crj.13711","article-title":"Safety outcomes of salbutamol: a systematic review and meta-analysis","volume":"17","author":"Ma","year":"2023","journal-title":"Clin Respir J"},{"key":"2026022301501357000_12.1.00741-2025.14","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2007.080382"},{"key":"2026022301501357000_12.1.00741-2025.15","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42269-020-0271-y","article-title":"Evaluation of inhaled beta-2 agonist in management of transient tachypnoea of the newborn","volume":"44","author":"Talaat","year":"2020","journal-title":"Bull Natl Res Cent"},{"key":"2026022301501357000_12.1.00741-2025.16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.51273\/esc20.251636","article-title":"Efficacy of inhaled salbutamol in the management of transient tachypnoea of newborn","volume":"16","author":"Hussain","year":"2020","journal-title":"Esculapio"},{"key":"2026022301501357000_12.1.00741-2025.17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jcma.2018.01.015","article-title":"The effect of inhaled salbutamol on the outcomes of transient tachypnoea of the newborn","volume":"81","author":"Malakian","year":"2018","journal-title":"J Chin Med Assoc"},{"key":"2026022301501357000_12.1.00741-2025.18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.51642\/ppmj.v34i01.541","article-title":"Inhaled salbutamol in transient tachypnoea of newborn","volume":"34","author":"Anwar","year":"2023","journal-title":"Pak Postgrad Med J"},{"key":"2026022301501357000_12.1.00741-2025.19","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41372-024-02201-0","article-title":"Nebulized","volume":"45","author":"Dhaka","year":"2024","journal-title":"J Perinatol"},{"key":"2026022301501357000_12.1.00741-2025.20","first-page":"42","article-title":"Effects of salbutamol on the treatment of transient tachypnoea of the newborn","volume":"10","author":"Babaei","year":"2019","journal-title":"Iran J Neonatol"},{"key":"2026022301501357000_12.1.00741-2025.21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/jamp.2023.0043","article-title":"Safety and efficacy of 2.5\u2005mg and 1.25\u2005mg nebulized salbutamol compared with placebo on transient tachypnoea of the newborns: a triple-blind phase II\/III parallel randomised controlled trial","volume":"37","author":"Choobdar","year":"2024","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"2026022301501357000_12.1.00741-2025.22","first-page":"98","article-title":"The rule of inhaled salbutamol on the outcome of transient tachypnoea of newborn","volume":"4","author":"Hamed","year":"2022","journal-title":"Ann Neonatol"},{"key":"2026022301501357000_12.1.00741-2025.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71"},{"key":"2026022301501357000_12.1.00741-2025.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d5928"},{"key":"2026022301501357000_12.1.00741-2025.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.01.006"},{"key":"2026022301501357000_12.1.00741-2025.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2022.07.015"},{"key":"2026022301501357000_12.1.00741-2025.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-083864"},{"key":"2026022301501357000_12.1.00741-2025.28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081904"},{"key":"2026022301501357000_12.1.00741-2025.29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081905"},{"key":"2026022301501357000_12.1.00741-2025.30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.70749\/ijbr.v3i2.617","article-title":"Role of inhaled albuterol in the management of transient tachypnoea of newborn","volume":"3","author":"Hussain","year":"2025","journal-title":"Ind J Biosci Res"},{"key":"2026022301501357000_12.1.00741-2025.31","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.51253\/pafmj.v72i5.4746","article-title":"Role of salbutamol in the management of transient tachypnoea of the newborn: a comparative prospective study","volume":"72","author":"Ahmed","year":"2022","journal-title":"Pak Armed Forces Med J"},{"key":"2026022301501357000_12.1.00741-2025.32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.70749\/ijbr.v3i3.798","article-title":"Difference between role of nebulized salbutamol and nebulized normal saline in treatment of transient tachypnoea of new born","volume":"3","author":"Alvi","year":"2025","journal-title":"Indus J Biosci Res"},{"key":"2026022301501357000_12.1.00741-2025.33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jpeds.2011.02.028","article-title":"Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnoea of the newborn","volume":"159","author":"Armangil","year":"2011","journal-title":"J Pediatr"},{"key":"2026022301501357000_12.1.00741-2025.34","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.09284"},{"key":"2026022301501357000_12.1.00741-2025.35","doi-asserted-by":"crossref","first-page":"101","DOI":"10.51253\/pafmj.v72i1.6076","article-title":"Effects of salbutamol and furosemide in the treatment of transient tachypnoea of newborn \u2013 a randomised controlled trial","volume":"72","author":"Khushdil","year":"2022","journal-title":"Pak Armed Forces Med J"},{"key":"2026022301501357000_12.1.00741-2025.36","doi-asserted-by":"publisher","DOI":"10.4168\/aair.2014.6.2.126"},{"key":"2026022301501357000_12.1.00741-2025.37","first-page":"52","article-title":"Salbutamol nebulization for management of transient tachypnoea of newborn (TTN)","volume":"28","author":"Maroof","year":"2021","journal-title":"Prof Med J"},{"key":"2026022301501357000_12.1.00741-2025.38","first-page":"e9633","article-title":"The effect of inhaled salbutamol in transient of tachypnoea of the newborn: a randomised clinical trial","volume":"27","author":"Mohammadzadeh","year":"2017","journal-title":"Inn J Pediatr"},{"key":"2026022301501357000_12.1.00741-2025.39","first-page":"5","article-title":"Salbutamol inhalado en los ni\u00f1os reci\u00e9n nacidos con taquipnea transitoria. [","volume":"82","author":"Monzoy-Ventre","year":"2015","journal-title":"Rev Mex Pediatr"},{"key":"2026022301501357000_12.1.00741-2025.40","first-page":"e8211","article-title":"Effects of nebulized albuterol in transient tachypnoea of the newborn a clinical trial","volume":"27","author":"Mussavi","year":"2017","journal-title":"Inn J Pediatr"},{"key":"2026022301501357000_12.1.00741-2025.41","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4103\/ajop.ajop_22_22","article-title":"Comparison of inhaled salbutamol and intravenous furosemide in the treatment of transient tachypnoea of the newborn regarding their safety and efficacy","volume":"35","author":"Sabry","year":"2022","journal-title":"Alex J Pediatr"},{"key":"2026022301501357000_12.1.00741-2025.42","first-page":"457","article-title":"Inhaled salbutamol for the treatment of transient tachypnoea of the newborn","volume":"2","author":"Salama","year":"2020","journal-title":"Int J Med Arts"},{"key":"2026022301501357000_12.1.00741-2025.43","first-page":"CD013563","article-title":"Interventions for the management of transient tachypnoea of the newborn \u2013 an overview of systematic reviews","volume":"2","author":"Bruschettini","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"2026022301501357000_12.1.00741-2025.44","doi-asserted-by":"publisher","DOI":"10.1186\/cc2875"}],"container-title":["ERJ Open Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/23120541.00741-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T09:50:32Z","timestamp":1771840232000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/23120541.00741-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1183\/23120541.00741-2025"],"URL":"https:\/\/doi.org\/10.1183\/23120541.00741-2025","relation":{},"ISSN":["2312-0541"],"issn-type":[{"value":"2312-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]}}}